Acadia Pharmaceuticals Inc. Forecast and Target Price
$16.87
Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast
Currently 26 wall-street analysts regularly analyze the financials of Acadia Pharmaceuticals Inc. on a frequent basis to provide recommendations along with target share price. 26 analysts offering 12-month price forecasts for Acadia Pharmaceuticals Inc. (ACAD) have a share price target of $25.11. This median of share price forecast represents a 48.82% upside from the latest price of $16.87 as on 21.12.24.
Acadia Pharmaceuticals Inc. (ACAD) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Acadia Pharmaceuticals Inc. (ACAD) share price will touch around $25.11 in next 12-months.
Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Acadia Pharmaceuticals Inc.'s share price and its median forecast price. As on 21.12.24, the difference is -40.76%
Acadia Pharmaceuticals Inc. (ACAD): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Acadia Pharmaceuticals Inc. (ACAD) Share Price : Analyst Recommendation
Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 14 | 13 | 13 |
| Outperform | 6 | 6 | 6 |
| Hold | 6 | 7 | 6 |
| Underperform | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 |
Acadia Pharmaceuticals Inc. (ACAD) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
₹0 US Stocks a/c Opening Fee